GlaxoSmithKline plc’s US$13bn acquisition of 36.5% stake in its consumer health joint venture with Novartis AG

Paolo Bossi
Tagged:

Freshfields Bruckhaus Deringer has advised Novartis AG on the sale of its 36.5% stake in its consumer health joint venture with GlaxoSmithKline plc for US$13bn. The…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here